期刊文献+

人参皂苷对NLRP3炎性体激活的抑制作用 被引量:9

Inhibitory activities of ginsenosides on the activation of NLRP3 inflammasome
下载PDF
导出
摘要 为筛选可抑制NLRP3炎性体激活的人参皂苷,在用ATP、尼日利亚菌素(nigericin)和二氧化硅(silica)等NLRP3炎性体诱导剂诱导的小鼠腹腔巨噬细胞(PMs)中分别用17种人参皂苷(PPT,PPD,Rb1,Rb2,Rb3,Rc,Rd,Re,Rg1,Rg2,Gg3,Rh1,Rh2,Ro,Rh2,Ro,c K,F1,F2)进行处理,通过对IL-1β的分泌量进行分析,明确具有抗炎作用的人参皂苷单体。在ATP诱导组中,IL-1β的分泌量在人参皂苷PPT、PPD和F1处理后下降最为明显(P<0.001);而在尼日利亚菌素诱导组中,除了PPT、PPD及F1外,Rg3对IL-1β的分泌也具有较高的抑制效果;在二氧化硅诱导组中,可抑制IL-1β的分泌的皂苷种类较多,包括PPT、PPD、Rd、Rg3、Rb3、Rb2、F2、Re、F1和Rh2(P<0.001)。本研究结果表明,PPT、PPD和F1对3种不同炎性体诱导剂引起的NLRP3炎性体激活均具有较强抑制作用(P<0.001)。 To screen ginsenosides with inhibitory activities on the activation of NLRP3 inflammasome, 17 ginsen- osides ( PPT, PPD, Rbl, Rb2, Rb3, Rc, Rd, Re, Rgl, Rg2, Gg3, Rhl, Rh2, Ro, Rh2, Ro, cK, F1, F2) were used to treat mouse peritoneal macrophages (PMs) induced with NLRP3 inflammasome inducers (ATP, nigericin, or silica). In the present study, the higher anti-inflammatory activity of ginsenoside monomers were confirmed by analysis of IL-1β secretion in PMs. In the group of ATP induction, IL-1β secretion decreased after.ginsenoside treatments, the high inhibitory effect was found at treatments of PPT, PPD, and F1 (P 〈 0. 001). At the group of the nigericin, Rg3 also possessed higher inhibitory effect on IL-1β secretion except PlYl', PPD, and F1 (P 〈 0. 001). Furthermore, compared with groups of the ATP and nigericin, IL-1β secretion at the group of silica decreased after treatments of various ginsenoside monomers, including PPT, PPD, Rd, Rg3, Rb3, Rb2, F2, Re, F1, and Rh2 (P 〈0. 001). The present study indicates that PPT, PPD, and F1 can efficiently inhibit NLRP3 inflam- masome activation induced by different inducers.
作者 马瑞 田金华 姜君 金鑫 MA Rui TIAN Jinhua JIANG Jun JIN Xin(Key Laboratory of Natural Resources of Changbai Mountian & Functional Molecules, Ministry of Education, Yanbian University, Yanfi 133002 Department of Veterinary Medicine, Yanbian University, Yanji 133002 Animal Health Supervision Institute, Dunhua 133700, China)
出处 《中国药科大学学报》 CAS CSCD 北大核心 2016年第5期614-618,共5页 Journal of China Pharmaceutical University
基金 国家自然科学基金资助项目(No.81603365)~~
关键词 人参皂苷 IL-1Β ATP 尼日利亚菌素 二氧化硅 NLRP3炎性体 抑制作用 ginsenoside IL-1β ATP nigericin silica NLRP3 inflammasome inhibition
  • 相关文献

参考文献9

  • 1Kim JJ,Jo EK. NLRP3 inflammasome and host protection against bacterial infection [ J ]. J Korean Med Sci, 2013,28 ( l0 ) : 1415 - 1423.
  • 2魏祺,程晓曙.NLRP3炎性小体研究进展[J].基础医学与临床,2015,35(1):117-121. 被引量:15
  • 3蒋建烨,田湉,张艳.NLRP3炎症体与炎症性疾病[J].微生物学免疫学进展,2012,40(1):79-82. 被引量:7
  • 4张文华,江剑平.白介素-1β在炎性痛中的作用及其机制[J].生命科学,2010,22(3):291-295. 被引量:30
  • 5Ren K ,Tortes R. Role of interleukin-113 during pain and inflam-marion [ J ]. Brain Res Rev,2009,60 ( 1 ) : 57 - 64.
  • 6李金凤,谢笛,何平平,唐艳艳,涂玉林,尹凯.NLRP3炎性体与代谢性疾病的研究进展[J].生物化学与生物物理进展,2014,41(5):425-434. 被引量:14
  • 7Lyv JM,Yao Q,Chen C. Ginseng compounds:an update on their molecular mechanisms and medical applications [ J ]. Curr Vasc Pharmacol,2009,7 ( 3 ) :293 - 302.
  • 8王海南.人参皂苷药理研究进展[J].中国临床药理学与治疗学,2006,11(11):1201-1206.
  • 9Dong TTX, Cui XM, Song ZH,et al. Chemical assessment of roots of Panax notoginseng in China: regional and seasonal variations in its active constituents [ J ]. J Agric Food Chem, 2003,51 ( 16 ) : 4617 - 4623.

二级参考文献88

  • 1Leon LR. Cytokine regulation of fever: studies using gene knockout mice. J Appl Physiol, 2002, 92(6): 2648-55.
  • 2Obreja O, Rathee PK, Lips KS, et al. IL-1β potentiates heatactivated currents in rat sensory neurons: involvement of IL-1RI, tyrosine kinase, and protein kinase C. FASEB J, 2002, 16(12): 1497-503.
  • 3Dinarello CA. Interleukin-1. Cytokine Growth Factor Rev, 1997, 8 (4): 253-65.
  • 4Subramaniam S, Stansberg C, Cunningham C. The interleukin 1 receptor family. Dev Comp Immunol, 2004, 28(5): 415- 28.
  • 5Ren K, Tortes R. Role of interleukin-1β during pain and inflammation. Brain Res Rev, 2009, 60(1): 57-64.
  • 6Touzani O, Boutin H, Chuquet J, et al. Potential mechanisms of interleuldn-1 involvement in cerebral ischaemia. J Neuroimmunol, 1999, 100(1-2): 203-15.
  • 7Kimya Y, Akdis C, Cengiz C, et al. Plasma intedeukin-1β interleukin-and interleukin-1 receptor antagonist levels in pre-eclampsia. Eur J Obstet Gynecol Reprod Biol, 1997, 73 (1): 17-21.
  • 8Burger D, Dayer JM, Palmer G, et al. Is IL-1α good therapeutic target in the treatment of arthritis? Best Pract Res Clin Rheumatol, 2006, 20(5): 879-96.
  • 9Braddock M, Quinn A. Targeting IL-1 in inflammatory disease: new opportunities for therapeutic intervention. Nat Rev Drug Discov, 2004, 3(4): 330-9.
  • 10Ferreira SH, Lorenzetti BB, Bristow AF, et al. Interleukin-1 as a potent hyperalgesic agent antagonized by a tripeptide analogue. Nature, 1988, 334(6184): 698-700.

共引文献64

同被引文献134

引证文献9

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部